NextCure Inc. (NXTC)
0.78
0.00 (0.13%)
At close: Mar 03, 2025, 11:47 AM
NextCure Income Statement
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 |
| Revenue | n/a | n/a | n/a | 22.38M | 6.35M | n/a | n/a |
| Cost of Revenue | 3.68M | 4.48M | 4.3M | 46.55K | 34.22K | 1.68M | 582K |
| Gross Profit | -3.68M | -4.48M | -4.3M | 22.33M | 6.31M | -1.68M | -582K |
| Operating Income | -67.64M | -75.91M | -70.77M | -41.23M | -37.48M | -23.2M | -15.55M |
| Interest Income | n/a | 1.17M | 1.32K | 4.55K | 3.75K | n/a | n/a |
| Pretax Income | -62.72M | -74.73M | -69.39M | -36.6M | -33.74M | -22.8M | -15.47M |
| Net Income | -62.72M | -69.43M | -69.39M | -33.19M | -33.74M | -22.8M | -15.47M |
| Selling & General & Admin | 19.71M | 21.71M | 20.57M | 17.05M | 9.61M | 3.41M | 2.6M |
| Research & Development | 47.93M | 54.2M | 50.19M | 46.55M | 34.22M | 19.79M | 12.95M |
| Other Expenses | n/a | 1.18M | 1.38M | 4.62M | 3.75M | 397K | 80K |
| Operating Expenses | 67.64M | 75.91M | 70.77M | 63.6M | 43.83M | 23.2M | 15.55M |
| Interest Expense | n/a | n/a | 77K | 183K | 209K | n/a | n/a |
| Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Cost & Expenses | 67.64M | 75.91M | 70.77M | 63.6M | 43.83M | 23.2M | 15.55M |
| Income Tax | n/a | -5.3M | 6.96M | -3.41M | 2.52M | 397K | n/a |
| Shares Outstanding (Basic) | 27.84M | 27.74M | 27.62M | 27.53M | 15.7M | 10.04M | 10.04M |
| Shares Outstanding (Diluted) | 27.84M | 27.74M | 27.62M | 27.53M | 15.7M | 10.04M | 10.04M |
| EPS (Basic) | -2.25 | -2.5 | -2.51 | -1.21 | -2.15 | -2.27 | -1.54 |
| EPS (Diluted) | -2.25 | -2.5 | -2.51 | -1.21 | -2.15 | -2.27 | -1.54 |
| EBITDA | -59.04M | -70.25M | -65.01M | -37.81M | -34.79M | -21.1M | -14.97M |
| Depreciation & Amortization | 3.68M | 4.48M | 4.3M | 3.41M | 2.69M | 1.68M | 582K |